Biolife solutions reports immaterial financial exposure to silicon valley bank

Bothell, wash. , march 10, 2023 /prnewswire/ -- biolife solutions, inc. (nasdaq: blfs), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("cgt") and broader biopharma markets, today provided commentary on its current banking relationship with silicon valley bank ("svb").
BLFS Ratings Summary
BLFS Quant Ranking